Imvax's Independent Supported Session at SNO 2024
Development of IGV-001 for the treatment of newly diagnosed glioblastoma
22 November 2024, Friday. 12:45 PM to 1:45 PM CST, Convention Center, Room 360.
*
1.
I will attend Imvax's Independent Supported Session at SNO 2024.
(Required.)
Yes
No
2.
How did you hear about the event?
SNO 2024 Website
Invitation
Other (please specify)
*
3.
First Name
(Required.)
*
4.
Last Name
(Required.)
*
5.
Institution
(Required.)
*
6.
Role/Profession
(Required.)
Neuro-oncologist
Neuro-surgeon
Medical oncologist
Radiation oncologist
Advanced Practice Provider
Research/Study Co-Ordinator
Patient Advocate
Patient
Other (please specify)
7.
Do you have any dietary restrictions
No
Yes
8.
What topics would you most like to learn about or discuss at the ISS?
9.
Are there any specific questions you would like to be addressed at this event?
10.
Would you like to receive links to copies of data presented at this ISS?
Yes
No
